Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLB vs TAP Block for Laparoscopic Inguinal Hernia Repair
NCT03023462Completed
- Sponsor
- Ostfold Hospital Trust
- Start
- Sep 2019
- Primary completion
- Jun 2020
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Ostfold Hospital Trust. Primary endpoint: Opioid consumption measured in oral morphine equivalents at 4 hours. Started Sep 2019; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03023462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023462.